Lanean...
Engineered Fc based antibody domains and fragments as novel scaffolds
Therapeutic monoclonal antibodies (mAbs) have been successful for therapy of a number of diseases mostly cancer and immune disorders. However, the vast majority of mAbs approved for clinical use are full size, typically in IgG1 format. These mAbs may exhibit relatively poor tissue penetration and re...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185235/ https://ncbi.nlm.nih.gov/pubmed/24792384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbapap.2014.04.018 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|